Featured
Lilly's Retatrutride Lawsuits: The First Pre-Approval Black Market in Obesity Drug History
Eli Lilly filed six lawsuits, five in Texas, against sellers of unapproved retatrutride, a triple-agonist obesity drug that has not yet received FDA a...
Read Full Story →